Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry

  1. del Cañizo, M.C.
  2. Martínez, C.
  3. Conde, M.
  4. Vallejo, C.
  5. Brunet, S.
  6. Sanz, G.
  7. Mateos, M.V.
Journal:
Bone Marrow Transplantation

ISSN: 0268-3369

Year of publication: 2003

Volume: 32

Issue: 10

Pages: 987-992

Type: Article

DOI: 10.1038/SJ.BMT.1704246 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals